Particle size matters: Diagnostics and treatment of small airways involvement in asthma

European Respiratory Journal

Volumn 37, Issue 3, 2011, Pages 532-540

  Cohen, J ^a   Postma, D S ^a   Douma, W R ^a   Vonk, J M ^a   De Boer, A H ^a   Ten Hacken, N H T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Asthma; Bronchoprovocation; Nebuliser; Small airways

Indexed keywords

ADENOSINE PHOSPHATE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE;

ADULT; AEROSOL; AIRWAY; AIRWAY RESISTANCE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; MALE; OPEN STUDY; PARTICLE SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMALL AIRWAY; SPIROMETRY; TREATMENT DURATION;

ADENOSINE MONOPHOSPHATE; ADRENAL CORTEX HORMONES; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; MALE; NEBULIZERS AND VAPORIZERS; NITRIC OXIDE; PARTICLE SIZE; SPIROMETRY;

EID: 79953719969     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00204109     Document Type: Article

References (33)

1. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505-1510. (Pubitemid 26391205)
2. Roche WR. Inflammatory and structural changes in the small airways in bronchial asthma. Am J Respir Crit Care Med 1998; 157: S191-194.
3. Carroll N, Elliot J, Morton A, et al. The structure of large and small airways in nonfatal and fatal asthma. Am J Respir Crit Care Med 1993; 147: 405-410. (Pubitemid 23044915)
4. Saetta M, Di Stefano A, Rosina C, et al. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 148-143.
5. Verbanck S, Schuermans D, Paiva M, et al. The functional benefit of anti-inflammatory aerosols in the lung periphery. J Allergy Clin Immunol 2006; 118: 340-346. (Pubitemid 44142721)
6. Cohen J, Douma WR, Hacken NHT, et al. Ciclesonide improves measures of small airways involvement in asthma. Eur Respir J 2008; 31: 1213-1220.
7. Cohen J, Douma WR, van Ooijen PM, et al. Localization and quantification of regional and segmental air trapping in asthma. J Comput Assist Tomogr 2008; 32: 562-569.
8. Goldin JG, Tashkin DP, Kleerup EC, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999; 104: S258-S267. (Pubitemid 30005010)
9. Busse WW, Brazinsky S, Jacobson K, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999; 104: 1215-1222. (Pubitemid 30004983)
10. Taylor DA, Jensen MW, Kanabar V, et al. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-59-monophosphate in asthmatic patients. Am J Respir Crit Care Med 1999; 160: 237-243. (Pubitemid 29326094)
11. Leung SY, Eynott P, Nath P, et al. Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features. J Allergy Clin Immunol 2005; 115: 989-969.
12. Wilson AM, Duong M, Pratt B, et al. Anti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatic patients. Allergy 2006; 61: 537-542.
13. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, et al. Effect of ciclesonide and fluticasone on exhaled nitric oxide in patients with mild allergic asthma. Resp Med 2006; 100: 1651-1656. (Pubitemid 44089354)
14. Van Den Berge M, Meijer RJ, Kerstjens HA, et al. C20 adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med 2001; 163: 1546-1550. (Pubitemid 32578753)
15. Goldin JG, McNitt-Gray MF, Sorenson SM, et al. Airway hyperreactivity: assessment with helical thin-section CT. Radiology 1998; 208: 321-329. (Pubitemid 28373733)
16. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 53-83.
17. Hollie MC, Malone RA, Skufca RM, et al. Extreme variability in aerosol output of the DeVilbiss 646 jet nebulizer. Chest 1991; 100: 1339-1344.
18. Newman SP, Pellow PG, Clarke SW. In vitro comparison of DeVilbiss jet and ultrasonic nebulizers. Chest 1987; 92: 991-994.
19. Bendstrup KE, Newhouse MT, Pedersen OF, et al. Characterization of heparin aerosols generated in jet and ultrasonic nebulizers. J Aerosol Med 1999; 12: 17-25. (Pubitemid 29109296)
20. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Bethesda, National Institutes of Health and National Heart Lung and Blood Institute, 1995.
21. Newman SP, Pellow PGD, Clarke SW. Droplet size distributions of nebulised aerosols for inhalation therapy. Phys Physiol Meas 1986; 7: 139-146. (Pubitemid 16017978)
22. Lieutier-Colas F, Purohit A, Meyer P, et al. Bronchial challenge tests in patients with asthma sensitized to cats: the importance of large particles in the immediate response. Am J Respir Crit Care Med 2003; 167: 1077-1082. (Pubitemid 36459652)
23. Rottier BL, Cohen J, van der Mark TW, et al. A different analysis applied to a mathematical model on output of exhaled nitric oxide. J Appl Physiol 2005; 99: 378-380. (Pubitemid 40934509)
24. Borg G. Borg's perceived exertion and pain scales. Champaign, Human Kinetics Publishers, 1998.
25. Weibel ER, Gomez DM. Architecture of the human lung. Use of quantitative methods establishes fundamental relations between size and number of lung structures. Science 1962; 137: 577-585.
26. Balzar S, Wenzel SE, Chu HW. Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J 2002; 20: 254-259.
27. Hyatt RE. Expiratory flow limitation. J Appl Physiol 1983; 55: 1-7. (Pubitemid 13075314)
28. Casset A, Purohit A, Birba E, et al. Bronchial challenge test in asthmatics sensitized to mites: role of particle size in bronchial response. J Aerosol Med 2007; 20: 509-518.
29. Verbanck S, Schuermans D, Vincken W. Inflammation and airway function in the lung periphery of patients with stable asthma. J Allergy Clin Immunol 2010; 125: 611-616.
30. Lee DK, Haggart K, Currie GP, et al. Effects of hydrofluoroalkane formulations of ciclesonide 400 mg once daily vs fluticasone 250 mg twice daily on methacholine hyperresponsiveness in mild-tomoderate persistent asthma. Br J Clin Pharmacol 2004; 58: 26-33. (Pubitemid 38901463)
31. Derom E, Van De Velde V, Marissens S, et al. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 59-monophosphate in asthmatic patients. Pulm Pharmacol Ther 2005; 18: 328-336. (Pubitemid 40804531)
32. Kanniess F, Richter K, Böhme S, et al. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma. Pulm Pharmacol Ther 2001; 14: 141-147. (Pubitemid 32553619)
33. Manning P, Gibson PG, Lasserson TJ. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults. Cochrane Database Syst Rev 2008; 16: CD007031.